跳至主要内容
临床试验/TCTR20170303002
TCTR20170303002进行中(未招募)未知

Comparison of platelet aggregation of ticagrelor 180 mg, clopidogrel 600 mg loading dose and prasugrel 60 mg loading dose and correlation of response of platelet aggregation to CYP2C19*2, *3, and *17 single nucleotide polymorphisms in Thai patients w

Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 75 人开始时间: 2017年3月3日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 1. Thai patients who suspected to coronary heart disease and planned undergoing coronary angiography at King Chulalongkorn Memorial Hospital
  • 2. Thai patients who are competent to give informed consent

排除标准

  • 1. Pregnancy or breastfeeding
  • 2. History of hypersensitivity to clopidogrel ticagrelor หรือ prasugrel
  • 3. The patients who had shock, liver failure, severe infection, renal failure, or retain in emergency unit
  • 4. The patients who had bleeding disorder, history of gastrointestinal
  • bleeding, thrombocytopenia
  • 5. Receiving treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) except low dose aspirin (equal or less than 81 mg)
  • 6. Serum creatinine more than 2.5 mg/dl
  • 7. Participation in any other clinical trials within 30 days

研究者

发起方
Faculty of Medicine, Chulalongkorn University

相似试验